Product NDC: | 0069-4545 |
Proprietary Name: | DEXAMETHASONE SODIUM PHOSPHATE |
Non Proprietary Name: | DEXAMETHASONE SODIUM PHOSPHATE |
Active Ingredient(s): | 4 mg/mL & nbsp; DEXAMETHASONE SODIUM PHOSPHATE |
Administration Route(s): | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-4545 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040803 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110511 |
Package NDC: | 0069-4545-02 |
Package Description: | 25 VIAL in 1 CARTON (0069-4545-02) > 30 mL in 1 VIAL (0069-4545-01) |
NDC Code | 0069-4545-02 |
Proprietary Name | DEXAMETHASONE SODIUM PHOSPHATE |
Package Description | 25 VIAL in 1 CARTON (0069-4545-02) > 30 mL in 1 VIAL (0069-4545-01) |
Product NDC | 0069-4545 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DEXAMETHASONE SODIUM PHOSPHATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE |
Start Marketing Date | 20110511 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | DEXAMETHASONE SODIUM PHOSPHATE |
Strength Number | 4 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |